Biond Biologics is an Israeli clinical-stage biopharmaceutical company
Biond is an innovative biotech company developing breakthrough immunotherapies and a pioneering intracellular drug delivery platform for the treatment of cancer patients.
Our innovation:
Biologics targeting novel immune evasion mechanisms, discovered through in-house research utilizing real-world patient and tumor samples
A transformative intracellular delivery platform for biologics, e.g., antibodies or enzymes, inside cells, allowing to drug intracellular targets currently considered "undruggable".
Biond Biologics – Novel and innovative immunotherapies for cancer and auto-immune diseases.
Company Details
- Employees
- 41
- Founded
- -
- Address
- Misgav Industrial Park, Il
- Phone
- +972-4-8844337
- in****@****bio.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- biondbio.com
- Keywords
- Pharmaceuticals, drug development, Autoimmune, immuno-oncology, platform, Drug Delivery, Intracellular delivery of Biologics.
- HQ
- Misgav Industrial Park
Biond Biologics Ltd Questions
Biond Biologics Ltd's helpline number is +972-4-8844337
Biond Biologics Ltd's website is biondbio.com
Biond Biologics Ltd's LinkedIn profile is https://il.linkedin.com/company/biond-biologics-ltd
Biond Biologics Ltd has
41 employees.
View email and phone details for 41
employees at Biond Biologics Ltd.
Biond Biologics Ltd's industry is
Pharmaceutical Manufacturing
Biond Biologics Ltd's top competitors are
Pluri,
Adva Biotechnology,
Scinai Immunotherapeutics Ltd.,
Cytoreason,
Minovia Therapeutics,
Bonus Biogroup,
Protalix Biotherapeutics,
Memed,
Vivox - Experts In Vivo,
Biolinerx.
Biond Biologics Ltd's support email address is info@biondbio.com
Biond Biologics Ltd's categories are Pharmaceutical Manufacturing
Biond Biologics Ltd's founding year is 2016
